A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Completed · Phase 3 · Has a placebo group

Conditions studied: Psoriasis

In brief

The main objective of this study is to compare the effects of CP-690,550 with the effects of placebo in patients being treated for moderate to severe chronic plaque psoriasis. This one-year study will also evaluate the safety and tolerability of CP-690,550 versus placebo.

Key facts

Study ID

NCT01309737

Run by

Pfizer

People needed

960

Starts

2011-03-01

Expected to finish

2013-04-01

Last updated by the study team

2014-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older with diagnosis for at least 12 months of moderate to severe plaque psoriasis covering at least 10% of body surface area
• A Psoriasis Area and Severity Index (PASI) score of 12 or greater
• Are considered to be candidates for systemic or light therapy
• Have no evidence of active or latent tuberculosis

You may not qualify if…

• Non-plaque or drug-induced forms of psoriasis
• Cannot discontinue current oral, injectible or topical therapy for psoriasis or cannot discontinue phototherapy (PUVA or UVB)
• Any uncontrolled significant medical condition

Where it is running

• Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
• Bakersfield Dermatology and Skin Cancer Medical Group — Bakersfield, California, United States
• University of California San Diego — La Jolla, California, United States
• Dermatology Research Associates — Los Angeles, California, United States
• Expresscare Medical (X-Rays only) — Los Angeles, California, United States
• MedDerm Associates — San Diego, California, United States
• University of California San Diego — San Diego, California, United States
• Healthcare Partners Medical Group — Torrance, California, United States
• North Florida Dermatology Associates, PA — Jacksonville, Florida, United States
• Dermatologic Surgery Specialists, PC — Macon, Georgia, United States
• Sherman Immediate Care Center (Imaging Only) — Algonquin, Illinois, United States
• Schaumburg Dermatology — Schaumburg, Illinois, United States
• NorthShore University HealthSystem - Division of Dermatology — Skokie, Illinois, United States
• Dundee Dermatology — West Dundee, Illinois, United States
• Hudson Dermatology — Evansville, Indiana, United States
• Brigham & Women's Hospital — Boston, Massachusetts, United States
• Hamzavi Dermatology — Fort Gratiot, Michigan, United States
• Somerset Skin Centre - Dermcenter — Troy, Michigan, United States
• University of Minnesota - Department of Dermatology — Minneapolis, Minnesota, United States
• Saint Louis University - Department of Dermatology — St Louis, Missouri, United States
• Central Dermatology, PC — St Louis, Missouri, United States
• Bettencourt Skin Center — Henderson, Nevada, United States
• Dartmouth Hitchcock Medical Center - Section of Dermatology — Lebanon, New Hampshire, United States
• Comprehensive Clinical Research — Berlin, New Jersey, United States
• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.